Morningstar® Fund Report™

Overview
Chart
Performance
Risk and Rating
Portfolio
Management
Fees
Filings
Print 
PDF 
Methodology
Glossary 
Nippon India Pharma Fund - Growth
Performance History30/04/2024
Growth of 1,000 (INR)Advanced Graph
Performance History
Annual Returns30/04/2024
  20202021202220232024
Fund66.423.9-9.939.29.0
+/-Cat0.02.20.34.1-2.4
+/-Idx5.03.12.22.2-3.2
 
 
 
Trailing Returns03/05/2024
 Fund +/-Idx
YTD9.49 -3.26
3 Years Annualised15.62 1.10
5 Years Annualised23.32 3.08
10 Years Annualised16.87 4.27
 
 
12 Month Yield 0.00
 
Key Stats
Morningstar Medalist Rating™
 
-
Morningstar® Category
Sector - Healthcare
Morningstar Rating™
Not Rated
ISIN
INF204K01968
NAV   03/05/2024
INR 430.55
Day Change
0.16%
Fund Size (mil)
31/03/2024
71,252.85 INR
Share Class Size (mil)
-
Total Expense Ratio
1.83%
Initial Charge
0.00%
Exit Charge
1.00%
Manager Name
Manager Start Date
Sailesh Raj Bhan
Kinjal Desai
01/04/2005
25/05/2018
Inception Date
05/06/2004
Exchange Name
-
 
Benchmark
 
Fund Benchmark
S&P BSE Healthcare TR INR
Morningstar® Benchmark
S&P BSE Healthcare PR
 
Investment Objective
 
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
 
Portfolio Profile  31/03/2024
Morningstar Style Box®
Equity Style
Large, Mid, SmallSize
Value, Blend, Growth
Style
 
 
Asset Allocation %
  % Long% ShortNet Assets
Stocks97.160.0097.16
Bonds0.000.000.00
Cash2.980.142.84
Other0.000.000.00
 
Top 5 Regions%
Asia - Emerging100.00
United States0.00
Canada0.00
Latin America0.00
United Kingdom0.00
 
 
Top 5 Sectors%
Healthcare100.00
 
 
Top 5 HoldingsSector%
Sun Pharmaceuticals Industries Ltd HealthcareHealthcare14.91
Lupin Ltd HealthcareHealthcare8.40
Cipla Ltd HealthcareHealthcare6.51
Apollo Hospitals Enterprise Ltd HealthcareHealthcare5.79
Dr Reddy's Laboratories Ltd HealthcareHealthcare4.75